0.91 (-%)
As of Dec 06, 2024
Source:
Tempest Therapeutics, Inc. is a clinical-stage biotechnology company moving into late-stage development with a diverse portfolio of novel targeted and immune-mediated product candidates with the potential to be first-in-class treatments for a wide range of cancers.
Country | United States |
Headquarters | brisbane, california |
Phone Number | (415) 798-8589 |
Industry | manufacturing |
CEO | Stephen Brady |
Website | www.Tempesttx.com |